Alexandria Real Estate Equities Inc_ logo and website-by T_Schneider via Shutterstock

Pasadena, California-based Alexandria Real Estate Equities, Inc. (ARE) is a best-in-class, mission-driven life science REIT making a positive and lasting impact on the world. Valued at $12.3 billion by market cap, the company acquires, manages, expands, and develops office and laboratory space properties. It leases its properties to pharmaceutical, biotechnology, diagnostic and personal care products companies, research institutions, and related government agencies.

Companies worth $10 billion or more are generally described as “large-cap stocks,” and ARE perfectly fits that description, with its market cap exceeding this mark, underscoring its size, influence, and dominance within the REIT - office industry. ARE has pioneered life science real estate, establishing itself as a market leader, by focusing on innovation-driven sectors like life science, agtech, and technology. Strategic investments in Class A properties and collaborative environments create a dynamic ecosystem, boosting competitiveness. With a presence in key markets like Greater Boston, San Francisco Bay Area, and New York City, ARE benefits from geographical diversity, mitigating risks and unlocking revenue opportunities.

More News from Barchart

Robotaxis, Powell and Other Key Things to Watch this Week Is Quantum Computing (QUBT) Stock a Buy on This Bold Technological Breakthrough? The 7 Signs Your Stock Is A Buyout Target Tired of missing midday reversals? The FREE Barchart Brief newsletter keeps you in the know. Sign up now!

Despite its notable strength, ARE slipped 45.2% from its 52-week high of $130.14, achieved on Jul. 18, 2024. Over the past three months, ARE stock declined 26.4%, underperforming the Real Estate Select Sector SPDR Fund’s (XLRE) marginal losses during the same time frame.www.barchart.com

In the longer term, shares of ARE dipped 26.8% on a YTD basis and fell 38.1% over the past 52 weeks, significantly underperforming XLRE’s YTD gains of 2.9% and 9% returns over the last year.

To confirm the bearish trend, ARE has been trading below its 50-day moving average over the past year, experiencing some fluctuations. The stock is trading below its 200-day moving average since late July, 2024, with some fluctuations.www.barchart.com

ARE's underperformance is due to ongoing weakness in the office real estate market, exacerbated by remote work trends.

On Apr. 28, ARE reported its Q1 results, and its shares closed down more than 5% in the following trading session. Its adjusted FFO of $2.30 per share surpassed Wall Street expectations of $2.28 per share. The company’s revenue was $758.2 million, topping Wall Street forecasts of $749.5 million. ARE expects full-year adjusted FFO in the range of $9.16 to $9.36 per share.

Story Continues

In the competitive arena of REIT - office, Kilroy Realty Corporation (KRC)has taken the lead over ARE, showing resilience with a 13.3% downtick on a YTD basis and a 10.8% rise over the past 52 weeks.

Wall Street analysts are moderately bullish on ARE’s prospects. The stock has a consensus “Moderate Buy” rating from the 13 analysts covering it, and the mean price target of $97.31 suggests a potential upside of 36.3% from current price levels.

On the date of publication, Neha Panjwani did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Barchart.com

View Comments